Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Surgery, University of Montreal, Montreal, Quebec, Canada.
J Endourol. 2024 Jun;38(6):598-604. doi: 10.1089/end.2023.0503.
There are minimal data to guide antibiotic management of patients undergoing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia. Specifically, management of high-risk patients who are catheter dependent or have positive preoperative urine cultures varies widely. We aimed to evaluate the effect of preoperative antibiotic duration on infectious complications in high-risk patients undergoing HoLEP. A multi-institutional retrospective review of patients undergoing HoLEP between 2018 and 2023 at five institutions was performed. Patients were defined as high risk if they were catheter-dependent (indwelling urethral catheter, self-catheterization, or suprapubic tube) or had a positive preoperative urine culture. These patients were categorized into long course (>3 days) or short course (≤3 days) of preoperative antibiotics. The primary outcome was 30-day infectious complications defined as a positive urine culture with symptoms. A -test or Wilcoxon rank-sum test was used for continuous variables and Fisher's exact test was used for categorical variables. Logistic regression analysis was conducted to identify associations with infectious complications. Our cohort included 407 patients, of which 146 (36%) and 261 (64%) were categorized as short course and long course of preoperative antibiotics, respectively. Median preoperative antibiotic duration was 1 day (interquartile range [IQR]: 0, 3 days) and 7 days (IQR: 5, 7 days) in the short and long cohorts, respectively. Thirty-day postoperative infectious complications occurred in 11 (7.6%) patients who received a short course of antibiotics and 5 (1.9%) patients who received a long course of antibiotics (odds ratio 0.24, 95% confidence interval 0.07-0.67; = 0.009). Variables such as age, positive urine culture, and postoperative antibiotic duration were not significantly associated with postoperative infection after propensity score weighting. In high-risk patients undergoing HoLEP, infectious complications were significantly lower with a long course short course of antibiotics. Further prospective trials are needed to identify optimal preoperative antibiotic regimens.
对于因良性前列腺增生而接受钬激光前列腺剜除术(HoLEP)的患者,目前仅有少量数据可用于指导抗生素管理。特别是对于依赖导管或术前尿液培养阳性的高危患者,其管理方法差异很大。我们旨在评估术前抗生素使用时间对接受 HoLEP 的高危患者发生感染性并发症的影响。
对 5 家机构在 2018 年至 2023 年间接受 HoLEP 的患者进行了一项多机构回顾性研究。如果患者依赖导管(留置导尿管、自行导尿或耻骨上导管)或术前尿液培养阳性,则将其定义为高危患者。这些患者被分为术前抗生素使用长疗程(>3 天)或短疗程(≤3 天)。主要结局为 30 天内发生的感染性并发症,定义为有症状的阳性尿液培养。连续性变量采用 -检验或 Wilcoxon 秩和检验,分类变量采用 Fisher 确切检验。采用逻辑回归分析来确定与感染性并发症相关的因素。
我们的队列包括 407 例患者,其中 146 例(36%)和 261 例(64%)患者分别归类为短疗程和长疗程术前抗生素。短疗程和长疗程患者的术前抗生素中位使用时间分别为 1 天(四分位距 [IQR]:0,3 天)和 7 天(IQR:5,7 天)。接受短疗程抗生素的 11 例(7.6%)患者和接受长疗程抗生素的 5 例(1.9%)患者在术后 30 天内发生了术后感染性并发症(比值比 0.24,95%置信区间 0.07-0.67; = 0.009)。在进行倾向评分加权后,年龄、阳性尿液培养和术后抗生素使用时间等变量与术后感染均无显著相关性。
在接受 HoLEP 的高危患者中,长疗程抗生素短疗程抗生素可显著降低感染性并发症的发生率。需要进一步开展前瞻性试验来确定最佳的术前抗生素方案。